Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,408
-$400 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,791
of 2,821 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prudent Man Investment Management, Inc. holds $279,538 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
350 | $88,889 | |
| 2 | LLY |
ELI LILLY & Co
|
71 | $85,159 | |
| 3 | ABBV |
AbbVie Inc.
|
215 | $54,102 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
132 | $16,676 | |
| 5 | NVS |
Novartis AG
|
84 | $13,164 | |
| 6 | MRK |
Merck & Co., Inc.
|
100 | $12,850 | |
| 7 | GSK |
GSK plc
|
120 | $6,290 | |
| 8 | PFE |
Pfizer Inc
This page
|
100 | $2,408 |
All Filings in PFE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,408 | 100 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,808 | 100 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,490 | 100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,510 | 334 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $8,096 | 334 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $8,463 | 334 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $8,861 | 334 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||